Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers

被引:8
作者
Dobson, Ruth [1 ]
Topping, Joanne [1 ]
Giovannoni, Gavin [1 ]
机构
[1] Queen Mary Univ, Ctr Neurosci & Trauma, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England
关键词
Epstein-Barr virus; multiple sclerosis; ELISA; diagnostic accuracy; EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; RISK;
D O I
10.1002/jmv.23446
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
High IgG titers against the EpsteinBarr virus nuclear antigen, EBNA-1, have been strongly correlated with the risk of developing multiple sclerosis. ELISAs are used frequently to measure EBNA-1 titers, however concerns remain regarding the accuracy of results. Ordering absolute results into rank quintiles for analysis may be preferable. Using 120 serum samples, two commercially available ELISAs (produced by DiaSorin and VirionSerion) were compared, both in terms of absolute results and rank quintiles. The positive predictive value of the VirionSerion ELISA was 99.1% when compared to the DiaSorin ELISA, however, the negative predictive value was 64.3%. Sensitivity and specificity were acceptable at 95.5% and 90.0%, respectively. There was poor correlation between absolute results, R2?=?0.49; and the kappa coefficient for rank quintiles was low at 0.23. Although sensitivity and specificity appear adequate, the poor negative predictive value and kappa coefficient are of major concern. Care must be taken when selecting assays for experimental use. J. Med. Virol. 85:128131, 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 8 条
  • [1] Epstein-Barr virus and multiple sclerosis
    Ascherio, A
    Munch, M
    [J]. EPIDEMIOLOGY, 2000, 11 (02) : 220 - 224
  • [2] Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
    Ascherio, A
    Munger, KL
    Lennette, ET
    Spiegelman, D
    Hernán, MA
    Olek, MJ
    Hankinson, SE
    Hunter, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24): : 3083 - 3088
  • [3] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [4] Evaluation of Four Commercial Systems for the Diagnosis of Epstein-Barr Virus Primary Infections
    de Ory, Fernando
    Eulalia Guisasola, Maria
    Carlos Sanz, Juan
    Garcia-Bermejo, Isabel
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (03) : 444 - 448
  • [5] Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up
    DeLorenze, Gerald N.
    Munger, Kassandra L.
    Lennette, Evelyn T.
    Orentreich, Norman
    Vogelman, Joseph H.
    Ascherio, Alberto
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (06) : 839 - 844
  • [6] Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
    Levin, LI
    Munger, KL
    Rubertone, MV
    Peck, CA
    Lennette, ET
    Spiegelman, D
    Ascherio, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (20): : 2496 - 2500
  • [7] Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
    Munger, Kassandra L.
    Levin, Lynn I.
    Hollis, Bruce W.
    Howard, Noel S.
    Ascherio, Alberto
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (23): : 2832 - 2838
  • [8] Pakpoor J., 2012, MULT SCLER